June 9, 2017 / 2:39 AM / 2 months ago

BRIEF-Shanghai Fosun Pharmaceutical Group unit gets Ukraine approval for clinic trials

June 9 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd :

* Says its controlling unit gets Ministry of Public Health of Ukraine's approval for clinic trials of recombinant human monoclonal antibody against HER2 for injection, which is used for treatment of metastatic breast cancer

Source text in Chinese: goo.gl/zWCf7s

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below